The document provides an overview of intellectual property rights (IPR) and regulatory affairs, focusing on various forms of protection such as copyrights, trademarks, and patents, particularly in the pharmaceutical sector. It discusses the rights granted to creators, the duration of protection for different types, and the implications of patent infringement. Additionally, it outlines the role and scope of regulatory affairs professionals in ensuring the safety and efficacy of pharmaceuticals and related products.